Related references
Note: Only part of the references are listed.Developing a multiepitope vaccine for the prevention of SARS-CoV-2 and monkeypox virus co-infection: A reverse vaccinology analysis
Fan Jiang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2023)
Adenovirus in a Kidney Transplant Recipient
Erik L. Lum et al.
KIDNEY MEDICINE (2023)
Human adenovirus lung disease: outbreaks, models of immune-response-driven acute lung injury and pandemic potential
Jay R. Radke et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2023)
Risk assessment of retinal vascular occlusion after COVID-19 vaccination
Jing-Xing Li et al.
NPJ VACCINES (2023)
Immunization with matrix-, nucleoprotein and neuraminidase protects against H3N2 influenza challenge in pH1N1 pre-exposed pigs
Eleni Vatzia et al.
NPJ VACCINES (2023)
Molecular epidemiology analysis of fowl adenovirus detected from apparently healthy birds in eastern China
Qingye Zhuang et al.
BMC VETERINARY RESEARCH (2023)
Oncolytic virotherapy: basic principles, recent advances and future directions
Danni Lin et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023)
COVID-19 Vaccines: Adenoviral Vectors
Catherine Jacob-Dolan et al.
ANNUAL REVIEW OF MEDICINE (2022)
What Is Cystic Fibrosis?
Tori M. Endres et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Human Papillomavirus E6/E7 oncogene transcripts as biomarkers for the early detection of cervical cancer
Sadhana M. Gupta et al.
JOURNAL OF MEDICAL VIROLOGY (2022)
A novel oncolytic virus induces a regional cytokine storm and safely eliminates malignant ascites of colon cancer
Shuang Dong et al.
CANCER MEDICINE (2022)
Intravesical immunotherapy with a GM-CSF armed oncolytic vesicular stomatitis virus improves outcome in bladder cancer
Coby Rangsitratkul et al.
MOLECULAR THERAPY-ONCOLYTICS (2022)
Effects of pre-existing anti-adenovirus antibodies on transgene expression levels and therapeutic efficacies of arming oncolytic adenovirus
Ryosuke Ono et al.
SCIENTIFIC REPORTS (2022)
Chimeric adenoviral (Ad5.F35) and listeria vector prime-boost immunization is safe and effective for cancer immunotherapy
John C. Flickinger et al.
NPJ VACCINES (2022)
Viral Vector Vaccine Development and Application during the COVID-19 Pandemic
Shaofeng Deng et al.
MICROORGANISMS (2022)
Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial
Daniel Jenkin et al.
LANCET MICROBE (2022)
Adenovirus disease after hematopoietic cell transplantation: A Japanese transplant registry analysis
Yoshihiro Inamoto et al.
AMERICAN JOURNAL OF HEMATOLOGY (2022)
Heparan Sulfate and Sialic Acid in Viral Attachment: Two Sides of the Same Coin?
Ivan Emmanuel Ramos-Martinez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Covid-19 Vaccines - Immunity, Variants, Boosters
Dan H. Barouch
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer
Mathieu J. F. Crupi et al.
FRONTIERS IN IMMUNOLOGY (2022)
CXCL10-armed oncolytic adenovirus promotes tumor-infiltrating T-cell chemotaxis to enhance anti-PD-1 therapy
Xiaofei Li et al.
ONCOIMMUNOLOGY (2022)
Study on the Canine Adenovirus Type 1 (CAdV-1) Infection in Domestic Dogs in Southern Italy
Francesco Mira et al.
PATHOGENS (2022)
Adenovirus vector system: construction, history and therapeutic applications
Anum Syyam et al.
BIOTECHNIQUES (2022)
Engineering strategies to enhance oncolytic viruses in cancer immunotherapy
Yaomei Tian et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
Ad5/3 is able to avoid neutralization by binding to erythrocytes and lymphocytes
Sadia Zafar et al.
CANCER GENE THERAPY (2021)
Adenovirus Vectors Expressing Eight Multiplex Guide RNAs of CRISPR/Cas9 Efficiently Disrupted Diverse Hepatitis B Virus Gene Derived from Heterogeneous Patient
Yuya Kato et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Oncolytic Adenoviruses for Cancer Therapy
Lorella Tripodi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Adenovirus: Epidemiology, Global Spread of Novel Types, and Approach to Treatment
Joseph P. Lynch et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Adenovirus Core Proteins: Structure and Function
Shermila Kulanayake et al.
VIRUSES-BASEL (2021)
The RGD-binding integrins αvβ6 and αvβ8 are receptors for mouse adenovirus-1 and-3 infection
Manuela Bieri et al.
PLOS PATHOGENS (2021)
Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy
Masmudur M. Rahman et al.
CANCERS (2021)
Therapeutic potential of interleukin-15 in cancer (Review)
Gheorghita Isvoranu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)
The Mechanisms of HBV-Induced Hepatocellular Carcinoma
Yu Jiang et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2021)
Fiber modifications enable fowl adenovirus 4 vectors to transduce human cells
Wenfeng Zhang et al.
JOURNAL OF GENE MEDICINE (2021)
Oncolytic Vaccinia Virus Gene Modification and Cytokine Expression Effects on Tumor Infection, Immune Response, and Killing
Tomoyoshi Inoue et al.
MOLECULAR CANCER THERAPEUTICS (2021)
Genetic and Chemical Capsid Modifications of Adenovirus Vectors to Modulate Vector-Host Interactions
Denice Weklak et al.
VIRUSES-BASEL (2021)
Adenovirus Armed With TNFa and IL2 Added to aPD-1 Regimen Mediates Antitumor Efficacy in Tumors Refractory to aPD-1
Victor Cervera-Carrascon et al.
FRONTIERS IN IMMUNOLOGY (2021)
Nasally inhaled therapeutics and vaccination for COVID-19: Developments and challenges
Jinxiang Xi et al.
MEDCOMM (2021)
Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery
Liwang Shi et al.
NANOSCALE (2021)
Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy Drugs
Vanessa Innao et al.
CURRENT ONCOLOGY (2021)
Epidemiology of human adenovirus associated with respiratory infection in southern Brazil
Veridiane Maria Pscheidt et al.
REVIEWS IN MEDICAL VIROLOGY (2021)
Adenovirus Vectors: Excellent Tools for Vaccine Development
Jun Chang
IMMUNE NETWORK (2021)
Human adenovirus binding to host cell receptors: a structural view
Aleksandra Cecylia Stasiak et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2020)
Chimeric oncolytic Ad5/3 virus replicates and lyses ovarian cancer cells through desmoglein-2 cell entry receptor
Lukasz Kuryk et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Oncolytic Virus Encoding a Master Pro-Inflammatory Cytokine Interleukin 12 in Cancer Immunotherapy
Hong-My Nguyen et al.
CELLS (2020)
The Importance of Poly(ethylene glycol) Alternatives for Overcoming PEG Immunogenicity in Drug Delivery and Bioconjugation
Thai Thanh Hoang Thi et al.
POLYMERS (2020)
Efficacy of an Oncolytic Adenovirus Driven by a Chimeric Promoter and Armed with Decorin Against Renal Cell Carcinoma
Wen Zhang et al.
HUMAN GENE THERAPY (2020)
Transduction Efficiency of Adenovirus Vectors in Endothelial Cells and Vascular Smooth Muscle Cells
Nikita Mokhashi et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2020)
A Single All-in-One Helper-Dependent Adenovirus to Deliver Donor DNA and CRISPR/Cas9 for Efficient Homology-Directed Repair
Donna J. Palmer et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
An Oncolytic Vaccinia Virus Armed with GM-CSF and IL-24 Double Genes for Cancer Targeted Therapy
Lili Deng et al.
ONCOTARGETS AND THERAPY (2020)
Lactoferrin-Hexon Interactions Mediate CAR-Independent Adenovirus Infection of Human Respiratory Cells
B. David Persson et al.
JOURNAL OF VIROLOGY (2020)
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Feng-Cai Zhu et al.
LANCET (2020)
Adenovirus and Immunotherapy: Advancing Cancer Treatment by Combination
Mizuho Sato-Dahlman et al.
CANCERS (2020)
Adenoviral Vectors Armed with PAPILLOMAVIRUs Oncogene Specific CRISPR/Cas9 Kill Human-Papillomavirus-Induced Cervical Cancer Cells
Eric Ehrke-Schulz et al.
CANCERS (2020)
Effective inhibition of cancer cells by recombinant adenovirus expressing EGFR-targeting artificial microRNA and reversed-caspase-3
Maoxiao Yan et al.
PLOS ONE (2020)
Extracellular Vesicles-Mimetic Encapsulation Improves Oncolytic Viro-Immunotherapy in Tumors With Low Coxsackie and Adenovirus Receptor
Yonghui Zhang et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Helper virus-free gutless adenovirus (HF-GLAd): a new platform for gene therapy
Jida Liu et al.
BMB REPORTS (2020)
Interferons α and β in cancer: therapeutic opportunities from new insights
Ernest C. Borden
NATURE REVIEWS DRUG DISCOVERY (2019)
An estimate of the total number of true human miRNAs
Julia Alles et al.
NUCLEIC ACIDS RESEARCH (2019)
Oncolytic viruses: how lytic must they be for therapeutic efficacy?
Maria Eugenia Davola et al.
ONCOIMMUNOLOGY (2019)
Oncolytic Virus-Based Cytokine Expression to Improve Immune Activity in Brain and Solid Tumors
Taylor M. Pearl et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?
Valeria Cagno et al.
VIRUSES-BASEL (2019)
Production of CRISPR/Cas9-Mediated Self-Cleaving Helper-Dependent Adenoviruses
Donna J. Palmer et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Human adenovirus type 26 uses sialic acid-bearing glycans as a primary cell entry receptor
Alexander T. Baker et al.
SCIENCE ADVANCES (2019)
Intracellular sensing of viral genomes and viral evasion
Hyun-Cheol Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Adenoviruses across the animal kingdom: a walk in the zoo
Balazs Harrach et al.
FEBS LETTERS (2019)
Bi-allelic Homology-Directed Repair with Helper-Dependent Adenoviruses
Donna J. Palmer et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Perspective on Adenoviruses: Epidemiology, Pathogenicity, and Gene Therapy
Brennetta J. Crenshaw et al.
BIOMEDICINES (2019)
Household Transmission of Human Adenovirus Type 55 in Case of Fatal Acute Respiratory Disease
Shuping Jing et al.
EMERGING INFECTIOUS DISEASES (2019)
Molecular Epidemiology of Circulating Human Adenovirus Types in Acute Conjunctivitis Cases in Chandigarh, North India
Mini P. Singh et al.
INDIAN JOURNAL OF MEDICAL MICROBIOLOGY (2018)
Molecular epidemiology of human adenovirus infections in Denmark, 2011-2016
Celine Barnadas et al.
JOURNAL OF CLINICAL VIROLOGY (2018)
Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5/3-D24-GM-CSF) in peritoneal mesothelioma mouse model
Lukasz Kuryk et al.
JOURNAL OF MEDICAL VIROLOGY (2018)
Hexons from adenovirus serotypes 5 and 48 differentially protect adenovirus vectors from neutralization by mouse and human serum
Andrew W. Harmon et al.
PLOS ONE (2018)
Polysialic acid is a cellular receptor for human adenovirus 52
Annasara Lenman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
THE ONCOLYTIC ADENOVIRUS DNX-2401 HAS ANTITUMOR ACTIVITY IN GLIOBLASTOMA
[Anonymous]
CANCER DISCOVERY (2018)
TNFa and IL-2 armed adenoviruses enable complete responses by anti-PD-1 checkpoint blockade
V. Cervera-Carrascon et al.
ONCOIMMUNOLOGY (2018)
Generation of infectious clone of bovine adenovirus type I expressing a visible marker gene
Jingjing Ren et al.
JOURNAL OF VIROLOGICAL METHODS (2018)
Human adenovirus load in respiratory tract secretions are predictors for disease severity in children with human adenovirus pneumonia
Leyun Xie et al.
VIROLOGY JOURNAL (2018)
An Oncolytic Virus Expressing a T-cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal Cells
Joshua D. Freedman et al.
CANCER RESEARCH (2018)
Gene Therapy for Cystic Fibrosis Lung Disease: Overcoming the Barriers to Translation to the Clinic
Martin Donnelley et al.
FRONTIERS IN PHARMACOLOGY (2018)
Oncolytic Adenovirus Harboring Interleukin-24 Improves Chemotherapy for Advanced Prostate Cancer
Li-jun Mao et al.
JOURNAL OF CANCER (2018)
Hepatitis C virus: Morphogenesis, infection and therapy
Vladimir Alexei Morozov et al.
WORLD JOURNAL OF HEPATOLOGY (2018)
Molecular Epidemiology of Human Adenovirus-Associated Febrile Respiratory Illness in Soldiers, South Korea
Jung Yeon Heo et al.
EMERGING INFECTIOUS DISEASES (2018)
Human Adenovirus Type 37 Uses αVβ1 and α3β1 Integrins for Infection of Human Corneal Cells
Rickard J. Storm et al.
JOURNAL OF VIROLOGY (2017)
Chimpanzee Adenovirus Vector Ebola Vaccine
Julie E. Ledgerwood et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
11R-P53 and GM-CSF Expressing Oncolytic Adenovirus Target Cancer Stem Cells with Enhanced Synergistic Activity
Sai-qun Lv et al.
JOURNAL OF CANCER (2017)
Oncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies
Sachin R. Jhawar et al.
FRONTIERS IN ONCOLOGY (2017)
The Oncolytic Adenovirus VCN-01 as Therapeutic Approach Against Pediatric Osteosarcoma
Naiara Martinez-Velez et al.
CLINICAL CANCER RESEARCH (2016)
Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9
Lili Deng et al.
CANCER LETTERS (2016)
Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based Constructs
Julio Alonso-Padilla et al.
MOLECULAR THERAPY (2016)
Oncolytic viruses: a new class of immunotherapy drugs (vol 14, pg 642, 2015)
Howard L. Kaufman et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Chimpanzee adenovirus vector-based avian influenza vaccine completely protects mice against lethal challenge of H5N1
Tao Cheng et al.
VACCINE (2016)
Insights into Adenovirus Uncoating from Interactions with Integrins and Mediators of Host Immunity
Glen R. Nemerow et al.
VIRUSES-BASEL (2016)
Oncolytic adenovirus expressing interleukin-18 improves antitumor activity of dacarbazine for malignant melanoma
Chunhua Yang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Components of Adenovirus Genome Packaging
Yadvinder S. Ahi et al.
FRONTIERS IN MICROBIOLOGY (2016)
CRISPR-Cas9 System as a Versatile Tool for Genome Engineering in Human Cells
Xuelian Wang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
Hemagglutinin-targeting Artificial MicroRNAs Expressed by Adenovirus Protect Mice From Different Clades of H5N1 Infection
Xinying Tang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
CRISPR-Cas: From the Bacterial Adaptive Immune System to a Versatile Tool for Genome Engineering
Marion Kirchner et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Silencing Daxx increases the anti-tumor activity of a TRAIL/shRNA Bcl-xL-expressing oncolytic adenovirus through enhanced viral replication and cellular arrest
Sujin Kang et al.
CELLULAR SIGNALLING (2015)
Adenovirus-mediated artificial MicroRNAs targeting matrix or nucleoprotein genes protect mice against lethal influenza virus challenge
H. Zhang et al.
GENE THERAPY (2015)
A Genetically Modified Adenoviral Vector with a Phage Display-Derived Peptide Incorporated into Fiber Fibritin Chimera Prolongs Survival in Experimental Glioma
Julius W. Kim et al.
HUMAN GENE THERAPY (2015)
Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans
Simona Bramante et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection
M. Jeyanathan et al.
MUCOSAL IMMUNOLOGY (2015)
Progress on adenovirus-vectored universal influenza vaccines
Kui Xiang et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Safety and Efficacy of VCN-01, an Oncolytic Adenovirus Combining Fiber HSG-Binding Domain Replacement with RGD and Hyaluronidase Expression
Alba Rodriguez-Garcia et al.
CLINICAL CANCER RESEARCH (2015)
A recombinant adenovirus bicistronically expressing porcine interferon-α and interferon-γ enhances antiviral effects against foot-and-mouth disease virus
Su-Mi Kim et al.
ANTIVIRAL RESEARCH (2014)
Encapsulation of adenovirus serotype 5 in anionic lecithin liposomes using a bead-based immunoprecipitation technique enhances transfection efficiency
Natalie Mendez et al.
BIOMATERIALS (2014)
Vaccination with tumor cells expressing IL-15 and IL-15Rα inhibits murine breast and prostate cancer
J. C. Morris et al.
GENE THERAPY (2014)
Adenovirus: The First Effective In Vivo Gene Delivery Vector
Ronald G. Crystal
HUMAN GENE THERAPY (2014)
Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans
Simona Bramante et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Cytokine Conditioning Enhances Systemic Delivery and Therapy of an Oncolytic Virus
Elizabeth Ilett et al.
MOLECULAR THERAPY (2014)
Protection of non-human primates against rabies with an adenovirus recombinant vaccine
Z. Q. Xiang et al.
VIROLOGY (2014)
The Evolution of Adenoviral Vectors through Genetic and Chemical Surface Modifications
Cristian Capasso et al.
VIRUSES-BASEL (2014)
Pre-existing immunity against Ad vectors Humoral, cellular, and innate response, what's important?
Hugues Fausther-Bovendo et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model
Wenjia Lou et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
The combination of an oxygen-dependent degradation domain-regulated adenovirus expressing the chemokine RANTES/CCL5 and NK-92 cells exerts enhanced antitumor activity in hepatocellular carcinoma
Jiang Li et al.
ONCOLOGY REPORTS (2013)
Interferon--armed oncolytic adenovirus induces both apoptosis and necroptosis in cancer cells
Hongling Huang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2012)
Human adenovirus infection in children with acute respiratory tract disease in Guangzhou, China
Lirong Zou et al.
APMIS (2012)
A Siglec-like sialic-acid-binding motif revealed in an adenovirus capsid protein
Christoph Rademacher et al.
GLYCOBIOLOGY (2012)
A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
Matthew D. J. Dicks et al.
PLOS ONE (2012)
A serological survey of human adenovirus serotype 2 and 5 circulating pediatric populations in Changchun, China, 2011
Bin Yu et al.
VIROLOGY JOURNAL (2012)
Suppression of hepatitis C virus replicon by adenovirus vector-mediated expression of tough decoy RNA against miR-122a
Fuminori Sakurai et al.
VIRUS RESEARCH (2012)
Helper-Dependent Adenovirus Is Superior to First-Generation Adenovirus for Expressing Transgenes in Atherosclerosis-Prone Arteries
Bo Jiang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
An effective gene-knockdown using multiple shRNA-expressing adenovirus vectors
Yukari Motegi et al.
JOURNAL OF CONTROLLED RELEASE (2011)
High-capacity adenoviral vectors circumvent the limitations of ΔE1 and ΔE1/ΔE3 adenovirus vectors to induce multispecific transgene product-directed CD8 T-cell responses
Matthias W. Kron et al.
JOURNAL OF GENE MEDICINE (2011)
Adenovirus type-35 vectors block human CD4+ T-cell activation via CD46 ligation
William C. Adams et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Multiple treatment cycles of liposome-encapsulated adenoviral RIP-TK gene therapy effectively ablate human pancreatic cancer cells in SCID mice
Shi-He Liu et al.
SURGERY (2011)
RNA interference in the clinic: challenges and future directions
Chad V. Pecot et al.
NATURE REVIEWS CANCER (2011)
Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
Howard L. Kaufman et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Unity and diversity in the human adenoviruses: exploiting alternative entry pathways for gene therapy
Kathryn Hall et al.
BIOCHEMICAL JOURNAL (2010)
Oncolytic adenovirus expressing interleukin-18 induces significant antitumor effects against melanoma in mice through inhibition of angiogenesis
J-N Zheng et al.
CANCER GENE THERAPY (2010)
Therapeutic potential of adenoviral vectors for delivery of expressed RNAi activators
Mohube Betty Mowa et al.
EXPERT OPINION ON DRUG DELIVERY (2010)
Anionic Liposomes Increase the Efficiency of Adenovirus-Mediated Gene Transfer to Coxsackie-Adenovirus Receptor Deficient Cells
Zhirong Zhong et al.
MOLECULAR PHARMACEUTICS (2010)
Selectivity of Oncolytic Viral Replication Prevents Antiviral Immune Response and Toxicity, but Does Not Improve Antitumoral Immunity
Engin Guerlevik et al.
MOLECULAR THERAPY (2010)
Phase II Clinical Trial of Intratumoral Application of TG1042 (Adenovirus-interferon-γ) in Patients With Advanced Cutaneous T-cell Lymphomas and Multilesional Cutaneous B-cell Lymphomas
Reinhard Dummer et al.
MOLECULAR THERAPY (2010)
A Universal Influenza A Vaccine Based on Adenovirus Expressing Matrix-2 Ectodomain and Nucleoprotein Protects Mice From Lethal Challenge
Dongming Zhou et al.
MOLECULAR THERAPY (2010)
An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector
Dongming Zhou et al.
NATURE PROTOCOLS (2010)
Chimeric Adenoviral Vectors Incorporating a Fiber of Human Adenovirus 3 Efficiently Mediate Gene Transfer Into Prostate Cancer Cells
Miho Murakami et al.
PROSTATE (2010)
Crystal Structure of Human Adenovirus at 3.5 Å Resolution
Vijay S. Reddy et al.
SCIENCE (2010)
Development of a nasal adenovirus-based vaccine: Effect of concentration and formulation on adenovirus stability and infectious titer during actuation from two delivery devices
Sandra S. Renteria et al.
VACCINE (2010)
Potent antitumor efficacy of interleukin-18 delivered by conditionally replicative adenovirus vector in renal cell carcinoma-bearing nude mice via inhibition of angiogenesis
Jun-Nian Zheng et al.
CANCER BIOLOGY & THERAPY (2009)
A Single Recombinant Adenovirus Expressing p53 and p21-targeting Artificial microRNAs Efficiently Induces Apoptosis in Human Cancer Cells
Masashi Idogawa et al.
CLINICAL CANCER RESEARCH (2009)
Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN
William C. Adams et al.
JOURNAL OF GENERAL VIROLOGY (2009)
Treatment of Pancreatic Cancer With an Oncolytic Adenovirus Expressing Interleukin-12 in Syrian Hamsters
Sergia Bortolanza et al.
MOLECULAR THERAPY (2009)
New Insights on Adenovirus as Vaccine Vectors
Marcio O. Lasaro et al.
MOLECULAR THERAPY (2009)
Adenovirus receptors: implications for tropism, treatment and targeting
Niklas Arnberg
REVIEWS IN MEDICAL VIROLOGY (2009)
Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors
Sampa Santra et al.
VACCINE (2009)
Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan Children, in the context of vaccine vector efficacy
M. Dudareva et al.
VACCINE (2009)
Bovine adenovirus serotype 3 utilizes sialic acid as a cellular receptor for virus entry
Xiaoxin Li et al.
VIROLOGY (2009)
Adenovirus receptors and their implications in gene delivery
Anurag Sharma et al.
VIRUS RESEARCH (2009)
Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves the Immune Response in Mice
Maria A. Croyle et al.
PLOS ONE (2008)
An Effective vaccine against colon cancer in mice: Use of recombinant adenoviruses interleukin-12 transduced dendritic cells
Xiao-Zhou He et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Role of Cellular Heparan Sulfate Proteoglycans in Infection of Human Adenovirus Serotype 3 and 35
Sebastian Tuve et al.
PLOS PATHOGENS (2008)
Helper-dependent adenovirus for the gene therapy of proliferative retinopathies: stable gene transfer, regulated gene expression and therapeutic efficacy
Stefania Lamartina et al.
JOURNAL OF GENE MEDICINE (2007)
A phase I clinical trial of an adenovirus-mediated endostatin gene (E10A) in patients with solid tumors
Xubin Lin et al.
CANCER BIOLOGY & THERAPY (2007)
Use of an oncolytic virus secreting GM-CSF as combined oncolytic and immunotherapy for treatment of colorectal and hepatic adenocarcinomas
Sandeep Malhotra et al.
SURGERY (2007)
Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Aβ1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease
Hong-Duck Kim et al.
JOURNAL OF GENE MEDICINE (2007)
Genital CD8+ T cell response to HIV-1 gag in mice immunized by mucosal routes with a recombinant simian adenovirus
Ana Paula D. de Souza et al.
VACCINE (2007)
A protocol for rapid generation of recombinant adenoviruses using the AdEasy system
Jinyong Luo et al.
NATURE PROTOCOLS (2007)
Oncolytic viruses driven by tumor-specific promoters
Jayson Hardcastle et al.
CURRENT CANCER DRUG TARGETS (2007)
Coxsackie adenovirus receptor and alpha nu beta 3/alpha nu beta 5 integrins in adenovirus gene transfer of rat cochlea
F. Venail et al.
GENE THERAPY (2007)
Members of adenovirus species B utilize CD80 and CD86 as cellular attachment receptors
Joshua J. Short et al.
VIRUS RESEARCH (2006)
A chimpanzee-origin adenovirus vector expressing the rabies virus glycoprotein as an oral vaccine against inhalation infection with rabies virus
Dongming Zhou et al.
MOLECULAR THERAPY (2006)
Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa
Zhiquan Xiang et al.
EMERGING INFECTIOUS DISEASES (2006)
Expression of the coxsackievirus- and adenovirus receptor in gastrointestinal cancer correlates with tumor differentiation
W. M. Korn et al.
CANCER GENE THERAPY (2006)
Adenovirus serotype 35 vector-mediated transduction into human CD46-transgenic mice
F. Sakurai et al.
GENE THERAPY (2006)
Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect
K-J Choi et al.
GENE THERAPY (2006)
Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo
WZ Chen et al.
JOURNAL OF VIROLOGY (2006)
Chimpanzee-origin adenovirus vectors as vaccine carriers
N Tatsis et al.
GENE THERAPY (2006)
CD46 is a cellular receptor for all species B adenoviruses except types 3 and 7
M Marttila et al.
JOURNAL OF VIROLOGY (2005)
Gutless adenovirus: last-generation adenovirus for gene therapy
R Alba et al.
GENE THERAPY (2005)
Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans
KR Van Kampen et al.
VACCINE (2005)
Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors
B Sangro et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Gene transduction and cell entry pathway of fiber-modified adenovirus type 5 vectors carrying novel endocytic peptide ligands selected on human tracheal glandular cells
F Gaden et al.
JOURNAL OF VIROLOGY (2004)
Functions and mechanisms of action of the adenovirus E3 proteins
DL Lichtenstein et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2004)
Adenoviruses as vaccine vectors
N Tatsis et al.
MOLECULAR THERAPY (2004)
Adenovirus type 11 uses CD46 as a cellular receptor
A Segerman et al.
JOURNAL OF VIROLOGY (2003)
Adenovirus-mediated interleukin-2 gene therapy of nociception
MZ Yao et al.
GENE THERAPY (2003)
CD46 is a cellular receptor for group B adenoviruses
A Gaggar et al.
NATURE MEDICINE (2003)
Adenovirus-mediated combined P16 gene and GM-CSF gene therapy for the treatment of established tumor and induction of antitumor immunity
LH Wang et al.
CANCER GENE THERAPY (2002)
New oncolytic adenoviruses with hypoxia- and estrogen receptor-regulated replication
R Hernandez-Alcoceba et al.
HUMAN GENE THERAPY (2002)
Adenovirus type 37 uses sialic acid as a cellular receptor on Chang C cells
N Arnberg et al.
JOURNAL OF VIROLOGY (2002)
Molecular regulation and biological function of adenovirus early genes:: the E4 ORFs
B Täuber et al.
GENE (2001)
A novel approach to cancer therapy using an oncolytic herpes virus to package amplicons containing cytokine genes
JF Carew et al.
MOLECULAR THERAPY (2001)
A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus
N Cheshenko et al.
GENE THERAPY (2001)
A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector
HS Zhou et al.
MOLECULAR THERAPY (2001)
Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies
KD Fisher et al.
GENE THERAPY (2001)
Efficient repetitive gene delivery to skeletal muscle using recombinant adenovirus vector containing the Coxsackievirus and adenovirus receptor cDNA
E Kimura et al.
GENE THERAPY (2001)
Production of first generation adenovirus vectors: a review
X Danthinne et al.
GENE THERAPY (2000)
Avian adenoviruses
JB McFerran et al.
REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES (2000)
Helper-dependent adenovirus vectors: their use as a gene delivery system to neurons
SP Cregan et al.
GENE THERAPY (2000)
Detection and differentiation of avian adenoviruses: a review
M Hess
AVIAN PATHOLOGY (2000)
Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse
DL Paielli et al.
MOLECULAR THERAPY (2000)
Adenovirus type 37 uses sialic acid as a cellular receptor
N Arnberg et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
